Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$101.51 - $125.27 $2.31 Million - $2.85 Million
-22,719 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $28,769 - $35,295
-335 Reduced 1.45%
22,719 $2.36 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $4.8 Million - $6.1 Million
-65,965 Reduced 74.1%
23,054 $1.98 Million
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $323,222 - $532,018
6,731 Added 8.18%
89,019 $6.53 Million
Q1 2020

May 08, 2020

BUY
$36.95 - $62.95 $165,092 - $281,260
4,468 Added 5.74%
82,288 $4.28 Million
Q4 2019

Feb 19, 2020

BUY
$47.06 - $56.64 $58,448 - $70,346
1,242 Added 1.62%
77,820 $4.38 Million
Q3 2019

Nov 05, 2019

SELL
$47.45 - $58.05 $51,767 - $63,332
-1,091 Reduced 1.4%
76,578 $3.65 Million
Q2 2019

Aug 12, 2019

BUY
$39.26 - $54.21 $8,833 - $12,197
225 Added 0.29%
77,669 $4.21 Million
Q1 2019

May 07, 2019

BUY
$29.84 - $43.92 $38,732 - $57,008
1,298 Added 1.7%
77,444 $3.14 Million
Q4 2018

Feb 13, 2019

BUY
$29.95 - $46.34 $52,053 - $80,538
1,738 Added 2.34%
76,146 $2.37 Million
Q3 2018

Nov 13, 2018

BUY
$40.12 - $45.55 $240,920 - $273,527
6,005 Added 8.78%
74,408 $3.39 Million
Q2 2018

Aug 14, 2018

BUY
$38.72 - $42.52 $55,834 - $61,313
1,442 Added 2.15%
68,403 $2.87 Million
Q1 2018

May 14, 2018

BUY
$39.4 - $47.39 $59,297 - $71,321
1,505 Added 2.3%
66,961 $2.75 Million
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $10,472 - $12,088
281 Added 0.43%
65,456 $2.69 Million
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $2.2 Million - $2.72 Million
65,175
65,175 $2.6 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.